8,300 Shares in Prestige Consumer Healthcare Inc. $PBH Purchased by Versor Investments LP

Key Points

• Versor Investments LP has acquired 8,300 shares of Prestige Consumer Healthcare Inc. (NYSE: PBH), valued at approximately $714,000, during the first quarter, indicating growing interest from institutional investors.
• Prestige Consumer Healthcare reported earnings per share (EPS) of $0.95 for the last quarter, missing the consensus estimate by $0.06, while revenue declined 6.6% year-over-year, totaling $249.53 million.
• The company's current consensus rating is "Hold", with analysts lowering their target price to $100.00, reflecting cautious sentiment towards its future performance.

Versor Investments LP acquired a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 8,300 shares of the company's stock, valued at approximately $714,000.

A number of other large investors have also modified their holdings of the company. Cerity Partners LLC increased its holdings in shares of Prestige Consumer Healthcare by 3.7% in the 1st quarter. Cerity Partners LLC now owns 3,666 shares of the company's stock worth $315,000 after acquiring an additional 132 shares during the period. KBC Group NV increased its stake in Prestige Consumer Healthcare by 7.4% during the 1st quarter. KBC Group NV now owns 2,199 shares of the company's stock valued at $189,000 after buying an additional 151 shares during the period. McIlrath & Eck LLC increased its stake in Prestige Consumer Healthcare by 19.1% during the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after buying an additional 154 shares during the period. Xponance Inc. increased its stake in Prestige Consumer Healthcare by 5.5% during the 1st quarter. Xponance Inc. now owns 3,766 shares of the company's stock valued at $324,000 after buying an additional 196 shares during the period. Finally, Resona Asset Management Co. Ltd. increased its stake in Prestige Consumer Healthcare by 2.3% during the 1st quarter. Resona Asset Management Co. Ltd. now owns 9,105 shares of the company's stock valued at $783,000 after buying an additional 203 shares during the period. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Stock Performance

NYSE:PBH opened at $64.93 on Tuesday. Prestige Consumer Healthcare Inc. has a twelve month low of $62.95 and a twelve month high of $90.04. The company has a current ratio of 4.38, a quick ratio of 2.99 and a debt-to-equity ratio of 0.55. The company has a 50-day moving average of $76.85 and a 200-day moving average of $81.54. The firm has a market cap of $3.20 billion, a price-to-earnings ratio of 15.24, a price-to-earnings-growth ratio of 2.05 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The business had revenue of $249.53 million for the quarter, compared to the consensus estimate of $260.71 million. During the same quarter last year, the business posted $0.90 EPS. The business's revenue for the quarter was down 6.6% on a year-over-year basis. Analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Canaccord Genuity Group lowered their target price on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Finally, Wall Street Zen cut shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.